Press

BARDA’s Division of Research, Innovation, and Ventures (DRIVe) has selected Jumpcode as a partner to develop a next-generation sequencing assay to diagnose respiratory viruses, including new and emerging pathogens.

BARDA’s Division of Research, Innovation, and Ventures (DRIVe) has selected Jumpcode as a partner to develop a next-generation sequencing assay to diagnose respiratory viruses, including new and emerging pathogens. This technology could aid in detecting any pathogen on day one of a public health emergency, providing better preparation for future pandemics. Jumpcode has partnered with …

BARDA’s Division of Research, Innovation, and Ventures (DRIVe) has selected Jumpcode as a partner to develop a next-generation sequencing assay to diagnose respiratory viruses, including new and emerging pathogens. Read More »

Jumpcode Genomics Launches CRISPRclean Single Cell RNA Boost Kit

CRISPRclean® technology improves single cell transcriptional profiling, enabling scientists to discover and see signals that were previously obscured by abundant genomic sequences  SAN DIEGO, Calif. – March 29, 2022 – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, today announced the launch of the CRISPRclean Single Cell RNA …

Jumpcode Genomics Launches CRISPRclean Single Cell RNA Boost Kit Read More »

Element Biosciences and Jumpcode Genomics Partner to Validate Jumpcode’s CRISPRclean® Technology on Element’s AVITI™ System for a Broad Set of Genomic Applications

Feb 24, 2022 SAN DIEGO, Calif., Feb 24, 2022 /PRNewswire/– Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a collaboration and co-marketing partnership with Jumpcode Genomics that validates Jumpcode’s CRISPRclean technology on Element’s AVITI System. The partnership has already demonstrated the value of pairing the technologies, promising improved data …

Element Biosciences and Jumpcode Genomics Partner to Validate Jumpcode’s CRISPRclean® Technology on Element’s AVITI™ System for a Broad Set of Genomic Applications Read More »

Jumpcode Genomics Names Brandon Poe Chief Financial Officer

Seasoned finance and life sciences executive, Brandon Poe, joins rapidly growing team, supporting company growth SAN DIEGO, CA – November 17, 2021 – Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, announced today that Brandon Poe has joined as Chief Financial Officer. Poe brings 25 years of financial …

Jumpcode Genomics Names Brandon Poe Chief Financial Officer Read More »

Jumpcode to Help Sequence COVID-19

In a new article from the San Diego Business Journal, Natallie Rocha speaks with Yaron Hakak, Jumpcode Genomics CEO, about a collaboration with the Translational Genomics Research Institute (TGen) to help sequence and examine the genomic epidemiology of SARS-CoV-2, the virus that causes COVID-19. The collaboration will give researchers the opportunity to examine the specificity …

Jumpcode to Help Sequence COVID-19 Read More »

Jumpcode Genomics and TGen Partner on Genomic Sequencing of COVID-19

Collaboration leverages CRISPRclean™ technology for genomic sequencing to help identify and track COVID-19 variants SAN DIEGO, Calif. — September 14, 2021 — Jumpcode Genomics, a genome technology platform company focused on improving the understanding of human biology, announced today a collaboration with the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, to …

Jumpcode Genomics and TGen Partner on Genomic Sequencing of COVID-19 Read More »

CRISPR-Cas9 Technology Cuts Clutter from Sequencing Libraries

In a new article from Genetic Engineering & Biotechnology News (GEN), Gail Dutton speaks with Yaron Hakak, Jumpcode Genomics CEO, on how our CRISPRclean™ technology can cut the clutter from sequencing libraries. Much of the information generated by next-generation sequencing is biologically uninformative, but this information keeps filling NGS libraries anyway, creating background noise and …

CRISPR-Cas9 Technology Cuts Clutter from Sequencing Libraries Read More »

Jumpcode Genomics Expands Team with Appointment of Three Executives

Welcomes Vice President of Research and Development, Vice President of Marketing and Vice President of Sales to fuel innovation and growth SAN DIEGO, Calif. — April 29, 2021 — Jumpcode Genomics, a genome technology platform company focused on enabling genomic analysis, today announced the appointment of three new key hires to its growing team. Jon …

Jumpcode Genomics Expands Team with Appointment of Three Executives Read More »

TGen, Jumpcode Genomics Marrying NGS, CRISPR to Build a Better COVID-19 Test

In a new article from GenomeWeb, Senior Editor Christie Rizk speaks with Nicholas Schork, Ph.D., Deputy Director and Distinguished Professor of Quantitative Medicine at The Translational Genomics Research Institute, about how Jumpcode’s CRISPRclean™ technology is helping researchers build a better COVID-19 test: While COVID-19 held the world in its grip throughout much of 2020, the …

TGen, Jumpcode Genomics Marrying NGS, CRISPR to Build a Better COVID-19 Test Read More »

Jumpcode Genomics Secures $21M in Series B Funding

Investors include Baird Capital, Arboretum Ventures and LYZZ Capital; funding will accelerate commercialization of CRISPRclean™ next-generation sequencing technology Life sciences industry veteran Frank Witney joins Jumpcode Board of Directors Jumpcode opens new headquarters in San Diego biotech business hub   SAN DIEGO, Calif. – Jan. 12, 2021 – Jumpcode Genomics – a genome technology company …

Jumpcode Genomics Secures $21M in Series B Funding Read More »

Contact Us Contact Us
Contact Us

Looking for more information? Need technical support?

Send Us A Message
Scroll to Top